首页 > 市场调查报告书 > 製药

生技设备生物工艺

市场调查报告书

商品编码

1672101

全球生物製程技术市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Bioprocess Technology Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 110 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球生物工艺技术市场规模预计将从 2024 年的 376.3 亿美元增长到 2033 年的 807.8 亿美元，在 2026 年至 2033 年的预测期内呈现 8.86% 的强劲年复合成长率(CAGR)。

受生物製药需求不断增长和高效生产流程需求的推动，生物製程技术市场正在经历显着增长。生物製程技术涵盖了用于开发和製造生物製品的一系列技术，包括疫苗、单株抗体和重组蛋白。随着全球生物製药产业的不断扩大，对提高生产力和降低成本的先进生物加工解决方案的需求不断增加。企业正在增加对生物製程技术的投资，以简化其製造流程并提高产品质量，从而为该市场的强劲扩张做好准备。

此外，生物製程技术的进步正在推动市场创新。连续製造流程、一次性技术和自动化解决方案的发展正在改变生物製药的生产方式。这些创新不仅提高了效率，还降低了污染风险并提高了可扩展性。随着生物製程技术市场不断发展，持续的研究和开发工作将在扩大可用解决方案范围以满足生物製药行业的多样化需求方面发挥关键作用。

此外，对个人化医疗和标靶治疗的日益重视正在塑造生物工艺技术格局。随着医疗保健提供者越来越多地寻求为个别患者量身定制治疗方案，对灵活且适应性强的生物加工解决方案的需求可能会增加。这一趋势在细胞和基因治疗领域尤其重要，因为生产客製化的生物製品需要先进的生物加工技术。随着生物製程技术市场持续成长，技术进步、法规遵循和个人化医疗的推动的整合将在塑造其未来发展轨迹方面发挥关键作用，确保生物製药公司能够满足医疗保健领域不断变化的需求。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第九章：生物製程技术公司的竞争格局

生物製程技术市场竞争
伙伴关係/合作/协议
合併与收购
新产品发布
其他进展

第十章：公司简介

顶级公司市占率分析
市场集中度
Thermo Fisher Scientific Inc.

公司概况
公司收入
产品
最新动态

Siemens Healthineers

公司概况
公司收入
产品
最新动态

GE Healthcare

公司概况
公司收入
产品
最新动态

Sartorius AG

公司概况
公司收入
产品
最新动态

Becton

公司概况
公司收入
产品
最新动态

Dickinson And Company

公司概况
公司收入
产品
最新动态

Danaher Corporation

公司概况
公司收入
产品
最新动态

Eppendorf AG

公司概况
公司收入
产品
最新动态

Lonza

公司概况
公司收入
产品
最新动态

Advanced Instruments

公司概况
公司收入
产品
最新动态

Nova Biomedical

公司概况
公司收入
产品
最新动态

F. Hoffmann-La Roche Ltd

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR11213676

Global Bioprocess Technology Market size is anticipated to grow from USD 37.63 Billion in 2024 to USD 80.78 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.86% during the forecast period of 2026 to 2033.

The bioprocess technology market is experiencing significant growth, driven by the increasing demand for biopharmaceuticals and the need for efficient production processes. Bioprocess technology encompasses a range of techniques used to develop and manufacture biological products, including vaccines, monoclonal antibodies, and recombinant proteins. As the global biopharmaceutical industry continues to expand, the demand for advanced bioprocessing solutions that enhance productivity and reduce costs is on the rise. Companies are increasingly investing in bioprocess technology to streamline their manufacturing operations and improve product quality, positioning this market for robust expansion.

Moreover, advancements in bioprocess technology are driving innovation within the market. The development of continuous manufacturing processes, single-use technologies, and automation solutions is transforming the way biopharmaceuticals are produced. These innovations not only enhance efficiency but also reduce the risk of contamination and improve scalability. As the bioprocess technology market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of solutions available to meet the diverse needs of the biopharmaceutical industry.

Additionally, the growing emphasis on personalized medicine and targeted therapies is shaping the bioprocess technology landscape. As healthcare providers increasingly seek to tailor treatments to individual patients, the demand for flexible and adaptable bioprocessing solutions is likely to rise. This trend is particularly relevant in the context of cell and gene therapies, where the production of customized biological products requires advanced bioprocessing techniques. As the bioprocess technology market continues to grow, the convergence of technological advancements, regulatory compliance, and the push for personalized medicine will play a pivotal role in shaping its future trajectory, ensuring that biopharmaceutical companies can meet the evolving demands of the healthcare landscape.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

Consumables & Accessories (Culture Media, Reagents, Others)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration)

By Application

Primary Surgical
Antibiotics
Recombinant Proteins
Monoclonal Antibodies
Biosimilar

By End-user

Biopharmaceutical Companies
Contract Manufacturing Organization
Contract Research Organization
Food & Feed Industry
Academic Research Organization
COMPANIES PROFILED
Thermo Fisher Scientific Inc.
Siemens Healthineers
GE Healthcare
Sartorius AG
Becton
Dickinson and Company
Danaher Corporation
Eppendorf AG
Lonza
Advanced Instruments
Nova Biomedical
F. Hoffmann-La Roche Ltd.
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BIOPROCESS TECHNOLOGY a€" INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Consumables & Accessories (Culture Media, Reagents, Others) Historic and Forecast Sales By Regions
5.4. Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Historic and Forecast Sales By Regions

6. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Primary Surgical Historic and Forecast Sales By Regions
6.4. Antibiotics Historic and Forecast Sales By Regions
6.5. Recombinant Proteins Historic and Forecast Sales By Regions
6.6. Monoclonal Antibodies Historic and Forecast Sales By Regions
6.7. Biosimilar Historic and Forecast Sales By Regions

7. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Biopharmaceutical Companies Historic and Forecast Sales By Regions
7.4. Contract Manufacturing Organization Historic and Forecast Sales By Regions
7.5. Contract Research Organization Historic and Forecast Sales By Regions
7.6. Food & Feed Industry Historic and Forecast Sales By Regions
7.7. Academic Research Organization Historic and Forecast Sales By Regions

8. GLOBAL BIOPROCESS TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BIOPROCESS TECHNOLOGY COMPANIES

9.1. Bioprocess Technology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF BIOPROCESS TECHNOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Siemens Healthineers
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. GE Healthcare
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Sartorius AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Becton
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Dickinson And Company
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Danaher Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Eppendorf AG
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Lonza
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Advanced Instruments
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Nova Biomedical
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. F. Hoffmann-La Roche Ltd
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Primary Surgical Market Sales By Geography (USD MN)
Antibiotics Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Biosimilar Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Contract Manufacturing Organization Market Sales By Geography (USD MN)
Contract Research Organization Market Sales By Geography (USD MN)
Food & Feed Industry Market Sales By Geography (USD MN)
Academic Research Organization Market Sales By Geography (USD MN)
Global Bioprocess Technology Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Bioprocess Technology Report
Market Research Process
Market Research Methodology
Global Bioprocess Technology Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-user
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Consumables & Accessories (Culture Media, Reagents, Others) Market Sales By Geography (USD MN)
Instruments (Bioprocess Analyzers, Blood Gas Analyzers, Osmometers, Cell Counter, Incubators, Bioreactors, Others (centrifugation, spectrometer, filtration) Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Primary Surgical Market Sales By Geography (USD MN)
Antibiotics Market Sales By Geography (USD MN)
Recombinant Proteins Market Sales By Geography (USD MN)
Monoclonal Antibodies Market Sales By Geography (USD MN)
Biosimilar Market Sales By Geography (USD MN)
Global Market Analysis By End-user (USD MN)
Biopharmaceutical Companies Market Sales By Geography (USD MN)
Contract Manufacturing Organization Market Sales By Geography (USD MN)
Contract Research Organization Market Sales By Geography (USD MN)
Food & Feed Industry Market Sales By Geography (USD MN)
Academic Research Organization Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis